Skip to main content
$2.72 $0.13 (5.0%)

12:24 PM EDT on 05/17/22

Clover Health (NASDAQ:CLOV)

CAPS Rating: 3 out of 5

Current Price $2.72 Mkt Cap $1.2B
Open $2.67 P/E Ratio 0.00
Prev. Close $2.59 Div. (Yield) $0.00 (0.0%)
Daily Range $2.64 - $2.75 Volume 3,915,077
52-Wk Range $1.95 - $28.85 Avg. Daily Vol. 8,650,173

Caps

How do you think NASDAQ:CLOV will perform against the market?

Add Stock to CAPS Watchlist

All Players

93 Outperform
9 Underperform
 

All-Star Players

5 Outperform
3 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:CLOV Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Margaritarius (< 20)
Submitted January 23, 2022

Speculative Pick (2% max allocation would be wise), Health Care Sector: Many companies who went public via SPACs have been gutted as those who rushed in, now rush out just as quickly, but many fail to realize that SPACs raised debt-free cash for… More

link8822 (83.71)
Submitted June 10, 2021

Stock squeeze will run out of steam and crash

NASDAQ:CLOV VS S&P 500 (SPY)

NASDAQ:CLOV Summary

Fools bullish on NASDAQ:CLOV are also bullish on:

Fools bearish on NASDAQ:CLOV are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CLOV.

Recs

0
Member Avatar jisifu (< 20) Submitted: 2/22/2022 1:24:15 AM : Outperform Start Price: $9.77 NASDAQ:CLOV Score: -78.10

I started writing a few articles on hc and tech changes.

https://clovchronicles.substack.com/

basically, clover has a huge TAM and a differentiable product and business model that has a durable sustainable advantage to their larger competition. The clover assistant is a software that presents useful information to the doctor about a patient and it's a bigger deal that one thinks when it comes to detecting diseases and making sure screening is regular.

it's really an interesting approach where an insurer is taking a proactive approach in preventive precision medicine.

Biggest difference from last year and this year is that they have 20+ patents now to solidify their technological moat. the patents give clover an opportunity to pave way to a new wave of adoption for info tech organizing capabilities by physicians.

lives that are managed by their software are +20% in gross margin over their counterparts who dont use the software. this is promising since the industry is known for relatively low margins between 10-15% with debt burden.

Recs

1
Member Avatar Margaritarius (< 20) Submitted: 1/23/2022 12:06:24 AM : Outperform Start Price: $2.37 NASDAQ:CLOV Score: +21.36

Speculative Pick (2% max allocation would be wise), Health Care Sector: Many companies who went public via SPACs have been gutted as those who rushed in, now rush out just as quickly, but many fail to realize that SPACs raised debt-free cash for these companies to accelerate their expansion into positive cash flows or outright profit margin; Clover is one such company; With a total debt to capital ratio of 4.61%, reported last Sept, she's operating at 1/10th the average debt ratio in her industry; Pretty smart move ahead of climbing interest rates if you ask me; CLOV also grew revenue 89% in the 3rd quarter as she expands her AI-enabled Medicare Advantage services into new states steadily stealing market share from the broader industry; Palihapatiya’s pick uses AI to bring providers and patients together; Providers actually recommend plans to patients so that they can get the care they need; Brilliant! It’s also recession proof; I’m likely to pass on a new EV when things get tight, but I’m pretty sure I’ll spring for coverage to get the health care I need to stay alive

Recs

1
Member Avatar link8822 (83.71) Submitted: 6/10/2021 1:32:01 AM : Underperform Start Price: $18.09 NASDAQ:CLOV Score: +80.81

Stock squeeze will run out of steam and crash

Leaderboard

Find the members with the highest scoring picks in CLOV.

Score Leader

TMFBwithbike

TMFBwithbike (40.51) Score: +267.54

The Score Leader is the player with the highest score across all their picks in CLOV.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
link8822 83.71 6/10/2021 Underperform 1Y $18.09 -84.94% -4.13% +80.81 1 Comment
TMFdjagielski 51.73 6/14/2021 Underperform 5Y $14.65 -81.40% -4.46% +76.94 0 Comment
baf72167 < 20 6/21/2021 Underperform 5Y $11.40 -76.10% -3.42% +72.68 0 Comment
TMFjimhalley 24.23 3/12/2021 Underperform 1Y $8.80 -69.03% +3.06% +72.09 1 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. Margaritarius < 20 1/24/2022 Outperform 5Y $2.37 +15.22% -6.14% +21.36 1 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. GoldMiner20 < 20 2/16/2022 Outperform 5Y $2.54 +7.43% -8.66% +16.09 0 Comment
TotoMMB 27.84 3/21/2022 Underperform 3Y $3.47 -21.43% -8.30% +13.13 0 Comment
HDTVBG 73.07 5/10/2022 Outperform 3W $2.47 +10.32% +0.83% +9.49 0 Comment
Under5b < 20 1/13/2022 Outperform 5Y $3.15 -13.35% -13.92% +0.56 0 Comment
farhangp < 20 5/10/2022 Outperform 5Y $2.76 -1.27% +0.25% -1.52 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CLOV.